Kidney Stem Cell Clinical Trials

Find clinical trials to treat kidney cancer.

Kidney stem cell clinical trials.

There are currently no fda approved treatments for kidney disease that use stem cells but researchers are conducting clinical trials to test whether stem cell based therapies for kidney diseases are safe and effective in humans. The harvard stem cell institute hsci kidney group has short medium and long term strategies to develop new therapies for diabetes related kidney damage diabetic nephropathy. Click here for their list of clinical trials which are currently. This phase iii trial compares nephrectomy surgery to remove a kidney or part of a kidney with nivolumab to the usual approach of nephrectomy followed by standard post operative follow up and monitoring in treating patients with kidney cancer that is limited to a certain part of the body localized.

Find open clinical trials related to regenerative medicine therapy. Hickson is part of the research team looking at using stem cells to help regenerate failing kidneys. Clinical trials are ongoing however with the goal of testing whether such therapies are effective and safe in humans. The website clinicaltrials gov has the most up to date information about the status of these trials.

Explore all clinical trials at mayo clinic. Our goal is to take a look at how we can repair the diabetic kidney in terms of delaying the rate of progression of kidney failure says latonya hickson m d a mayo clinic nephrologist. New therapies are being developed by the harvard stem cell institute to repair kidney damage and reduce the need for transplantation. Diabetic kidney disease also known as diabetic nephropathy is the most common cause of chronic kidney disease and end stage kidney failure requiring dialysis or kidney transplantation.

Currently there are no stem cell treatments for kidney disease that are approved by the fda. You will stay at the clinical center nih s research hospital for at least 2 weeks after the re infusion of the boostered t cells. Regenerative cell based therapy applying mscs holds promise to delay the progression of kidney disease in individuals with diabetes mellitus. Learn about volunteering in a clinical trial.

You are 18 or older. Scientists are working on a promising approach to treat chronic kidney disease and kidney failure by harnessing the unique properties of human amniotic fluid derived stem cells the mixture of stem cells that can be. Harvard university dedicates program specifically to kidney stem cell research for ckd and dialysis patients. Study related tests procedures and medications are provided at no cost.

You can browse trials categorized by disease or condition or by procedure or can use specific search terms and filter results by location study status gender study phase and more. This multi pronged approach aims to capitalize on promising translational achievements in the near future while pursing potential drugs and the ultimate goal of.